Nov 16, 2024 · Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.

Ranking in the top quartile of hematology and trasnplantation journals worldwide, we are the official publication of the EBMT. We provide wide exposure and high visibility for your publication...

Nov 29, 2024 · Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field. The content on this site is intended for healthcare professionals.

Journal article: Neidlein, S, Wirth, R, Pourhassan, M. Iron deficiency, fatigue and muscle strength and function in older hospitalized patients. Eur J Clin Nutr. 2020; 75:456–463.

Bone Marrow Transplantation is a peer-reviewed medical journal covering transplantation of bone marrow in humans. It is published monthly by Nature Research. The scope of the journal includes stem cell biology, transplantation immunology, translational research, and clinical results of specific transplant protocols. [1]

Jun 2, 2022 · Bone Marrow Transplantation is the official journal of EBMT, it publishes high quality, peer reviewed original research and reviews that address all aspects of basic biology and clinical use of haemopoietic cell transplantation.

EBMT data and statistical resources have resulted in more than 600 publications in peer-reviewed scientific journals since 1974. In addition, the EBMT as an organisation publishes a journal, Bone Marrow Transplantation, featuring high-quality, peer-reviewed original research and reviews in the field of haematopoietic cell transplantation.

In last month's issue, we covered the general evolution of bone marrow transplantation (BMT) leading up to the formation of the ASBMT. In this issue, we continue the story with insights and reflections from some of the founding members on the very first meeting of ASBMT.

Mar 5, 2021 · The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.

Objective: To systematically assess the efficacy of hematopoietic stem cell transplantation (HSCT) and bone marrow transplantation (BMT) in treating acute myeloid leukemia (AML). Methods: PubMed, EMBASE, ScienceDirect, Cochrane Library, China ...